- Boring CL, Squires TS, Tong T. Cancer statistics, 1992. CA Cancer
J Clin. 1992;42:3-8.
- Le Chevalier T, Brisgand D, Douillard J-Y, et al. Randomized study of
vinorelbine and cisplatin versus vindesine and cisplatin versus
vinorelbine alone in advanced non-small-cell lung cancer: results of a
European multicenter trial including 612 patients. J Clin Oncol.
1994;12:360-367.
- Zhou XJ, Lacarelle B, de Souza G, et al. In vitro biotransformation
of Navelbine by animal and human hepatic subcellular fractions. Bull
Cancer. 1990;77:586.
- ONS Clinical Practice Committee. Cancer Chemotherapy Guidelines:
Recommendations for the management of vesicant extravasation,
hypersensitivity, and anaphylaxis. Pittsburgh, Pa:
Oncology Nursing Society; 1992: 1-4.
Recommendations for the Safe Handling of Parenteral
Antineoplastic Drugs. Washington, DC: Division of Safety, National
Institutes of Health, US Department of Health and Human Services, Public
Health Service publication NIH 83-2621; 1983.
- AMA Council on Scientific Affairs. Guidelines for handling parenteral
antineoplastics. JAMA. 1985;253:1590-1592.
- Recommendations for the safe handling of cytotoxic drugs. Washington,
DC: US Dept of Health and Human Services, Public Health Service, National
Institutes of Health; 1992. National Institutes of Health publication
92-2621.
- Clinical Oncological Society of Australia. Guidelines and
recommendations for safe handling of antineoplastic agents. Med J
Australia. 1983;1:426-428.
- Jones RB, Frank R, Mass T. Safe handling of chemotherapeutic agents:
a report from the Mount Sinai Medical Center. CA-A Cancer J for
Clin. 1983;33:258-263.
- American Society of Hospital Pharmacists. ASHP technical assistance
bulletin on handling cytotoxic and hazardous drugs. Am J Hosp
Pharm. 1990;47:1033-1049.
- OSHA work-practice guidelines for personnel dealing with cytotoxic
(antineoplastic) drugs.
Am J Hosp Pharm. 1986;43:1193-1204.
- Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content
assessment of compatibility of vinorelbine tartrate with selected drugs
during simulated Y-site injection. Am J Hosp Pharm.
1994;51:495-499.
- Crawford J, O'Rourke MA. Vinorelbine (Navelbine)/ carboplatin
combination therapy: dose intensification with granulocyte
colony-stimulating factor. Semin Oncol. 1994;21(suppl 10):73-78.
